Evidence map›Paper›PMID 20631026›Full record

ArticleThe Journal of clinical endocrinology and metabolism2010

Naturally-occurring mutation in the calcium-sensing receptor reveals the significance of extracellular domain loop III region for class C G-protein-coupled receptor function.

Qing Dong, Zhiqiang Cheng, Wenhan Chang, Brigitte E Blackman, Felix A Conte, Jianxin Hu, Dolores Shoback, Walter L Miller

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.The Journal of clinical endocrinology and metabolism · 2020
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Qing DongDepartment of Pediatrics, University of California, San Francisco, San Francisco, California 94143-0434, USA. dongq@peds.ucsf.edu
Zhiqiang Cheng
Wenhan Chang
Brigitte E Blackman
Felix A Conte
Jianxin Hu
Dolores Shoback
Walter L Miller
University of California, San Francisco · USNational Institute of Diabetes and Digestive and Kidney Diseases · USSan Francisco VA Medical Center · US

Funding

Training Program in Pediatric EndocrinologyT32DK007161 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian J Feldman, STEPHEN E GITELMAN · 1986 to 2026
$6.2M
Molecular Biology of Steroidogenic ProteinsR01DK037922 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, WALTER L. · 1987 to 2011
$2.8M
CALCIUM-SENSING RECEPTORS AND GROWTH PLATE DEVELOPMENTR01AG021353 · NIA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI CHANG, WENHAN · 2002 to 2012
$2.5M
Conditional Knockout of Calcium Receptors in Bone CellsR01AR055588 · NIAMS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI SHOBACK, DOLORES M. · 2009 to 2013
$1.7M
Regulation of P450c17 Lyase Activity in AdrenacheK08DK064626 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DONG, QING · 2003 to 2007
$610k
NIAMS NIH HHS R01 AR055588NIAMS NIH HHS R01AR055588NIA NIH HHS R01 AG021353NIA NIH HHS R01AG21353-6NIDDK NIH HHS K08 DK064626NIDDK NIH HHS R01 DK037922NIDDK NIH HHS R01 DK37922NIDDK NIH HHS T32 DK007161
6 · The paper itself

Abstract

contextInactivating mutations of the calcium-sensing receptor (CaSR) cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Most mutations are clustered in the N-terminal and Cys-rich regions of the extracellular domain (ECD) and seven-transmembrane domain. Disease-causing mutations are uncommon in the C terminus of ECD.

objectiveThe aim of the study was to characterize the CaSR mutations causing neonatal severe hyperparathyroidism in a consanguineous family.

methodsParathyroid glands from the index patient were stained for CaSR protein. The CaSR gene was sequenced, mutations were recreated in CaSR cDNA, and HEK293 cells were transfected with the CaSR mutant expression vector. Cellular CaSR targeting was detected by immunoblotting and immunocytochemistry; CaSR activity was assayed by inositol phosphate accumulation, MAPK activation, and single-cell microfluorimetry.

resultsImmunocytochemistry showed reduced intracellular CaSR in patient parathyroids. An in-frame homozygous deletion/insertion mutation, c.1031 > 1034 (delACAAinsT), replaced His344-Asn345 with a single Leu in CaSR loop III. The mutant reduced cell surface expression of CaSR in transfected HEK293 cells. Inositol phosphate accumulation, MAPK activation, and single-cell microfluorimetry revealed blunted signaling responses of the mutant receptor to changes in extracellular Ca(2+) concentration.

conclusionDeletion of His344-Asn345 in the ECD loop III region affects cell surface targeting of CaSR in transfected cells and in affected parathyroid glands. Absence of conserved Asn345 may interfere with CaSR folding or glycosylation, leading to poor protein targeting to the cell membrane. This loss-of-function mutant indicates that the ECD loop III is required for CaSR activity.

Indexed as

MutationAmino Acid SequenceBase SequenceCalciumCells, CulturedConsanguinityFemaleGene DeletionHumansHypercalcemiaHyperparathyroidismInfantPedigreeProtein Structure, TertiaryReceptors, Calcium-SensingReceptors, G-Protein-CoupledCalciumReceptors, Calcium-SensingReceptors, G-Protein-Coupled

Identifiers

PMID20631026
PMCPMC3050095
OpenAlexW2114495995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.